SEC
|
LAWLIS V BRYAN
|
N/A
|
|
+13K
|
$1.18
|
+$15.69K
|
|
SEC
|
Samuels Scott Alan
|
EVP, Chief Legal Officer
|
|
+15K
|
$1.61
|
+$24.15K
|
|
SEC
|
SCARLETT JOHN A
|
Chairman, President and CEO
|
|
+13K
|
$1.77
|
+$22.13K
|
|
SEC
|
Ziegler James
|
EVP, Chief Commercial Officer
|
|
+100K
|
$1.60
|
+$160.00K
|
|
SEC
|
GRETHLEIN ANDREW J
|
EVP, Chief Operating Officer
|
|
-674K
|
$4.56
|
-$3.08M
|
|
SEC
|
Feller Faye
|
EVP, Chief Medical Officer
|
|
-288K
|
$4.63
|
-$1.33M
|
|
SEC
|
Kapur Anil
|
EVP, Corp Strategy & CCO
|
|
-422K
|
$4.64
|
-$1.96M
|
|
SEC
|
SCARLETT JOHN A
|
Chairman, President and CEO
|
|
-600K
|
$4.00
|
-$2.40M
|
|
SEC
|
LAWLIS V BRYAN
|
N/A
|
|
-35K
|
$3.75
|
-$131.25K
|
|
SEC
|
O'Farrell Elizabeth G.
|
N/A
|
|
+13K
|
$2.28
|
+$30.06K
|
|
SEC
|
LAWLIS V BRYAN
|
N/A
|
|
-35K
|
$3.00
|
-$105.00K
|
|
SEC
|
Molineaux Susan
|
N/A
|
|
-35K
|
$2.48
|
-$86.80K
|
|
SEC
|
GRETHLEIN ANDREW J
|
EVP, Chief Operating Officer
|
|
-235K
|
$2.60
|
-$610.27K
|
|
SEC
|
EASTHAM KARIN
|
N/A
|
|
+35K
|
$1.10
|
+$38.50K
|
|
SEC
|
Kapur Anil
|
EVP, Corp Strategy & CCO
|
|
+6K
|
$1.11
|
+$6.68K
|
|
SEC
|
GRETHLEIN ANDREW J
|
EVP, Chief Operating Officer
|
|
+235K
|
$1.70
|
+$399.02K
|
|
SEC
|
Kapur Anil
|
EVP, Corp Strategy & CCO
|
|
+13K
|
$1.11
|
+$14.50K
|
|
SEC
|
EASTHAM KARIN
|
N/A
|
|
+35K
|
$1.41
|
+$49.35K
|
|
SEC
|
O'Farrell Elizabeth G.
|
N/A
|
|
+17K
|
$1.73
|
+$30.17K
|
|
SEC
|
O'Farrell Elizabeth G.
|
N/A
|
|
+3K
|
$1.34
|
+$4.02K
|
|
SEC
|
BEHRS MELISSA KELLY
|
EVP, Chief Business Officer
|
|
-121K
|
$2.00
|
-$241.27K
|
|
SEC
|
BEHRS MELISSA KELLY
|
EVP BD and Port&Alliance Mgmt
|
|
-2.4K
|
$3.84
|
-$9.14K
|
|
SEC
|
Bloom Olivia Kyusuk
|
EVP, Chief Financial Officer
|
|
-2.4K
|
$3.84
|
-$9.14K
|
|
SEC
|
Hofstaetter Thomas
|
N/A
|
|
-70K
|
$4.10
|
-$287.00K
|
|
SEC
|
BEHRS MELISSA KELLY
|
EVP Portfolio & Alliance Mgmt
|
|
-4.8K
|
$2.10
|
-$10.13K
|
|
SEC
|
Bloom Olivia Kyusuk
|
EVP, Chief Financial Officer
|
|
-3.4K
|
$2.10
|
-$7.10K
|
|
SEC
|
BRADBURY DANIEL
|
N/A
|
|
+143K
|
$1.75
|
+$249.86K
|
|
SEC
|
BEHRS MELISSA KELLY
|
EVP Portfolio & Alliance Mgmt
|
|
-12K
|
$2.13
|
-$26.22K
|
|
SEC
|
Bloom Olivia Kyusuk
|
EVP, Chief Financial Officer
|
|
-7.4K
|
$2.13
|
-$15.84K
|
|
SEC
|
SCARLETT JOHN A
|
President and CEO
|
|
+50K
|
$1.03
|
+$51.50K
|
|
SEC
|
BEHRS MELISSA KELLY
|
SVP Alliance and Prog Mgmt
|
|
-28K
|
$1.65
|
-$46.68K
|
|
SEC
|
BEHRS MELISSA KELLY
|
SVP Strategic Portfolio Mgmt
|
|
-19K
|
$1.37
|
-$25.91K
|
|
SEC
|
Bloom Olivia Kyusuk
|
VP, Chief Acctg Officer
|
|
-11K
|
$1.37
|
-$15.11K
|
|
SEC
|
EARP DAVID
|
SVP, Corp Transactions
|
|
-27K
|
$1.37
|
-$37.20K
|
|
SEC
|
Kelsey Stephen Michael
|
EVP, R&D Head, CMO
|
|
-9.3K
|
$1.37
|
-$12.74K
|
|
SEC
|
KILEY THOMAS
|
N/A
|
|
+64K
|
$1.56
|
+$100.27K
|
|
SEC
|
KILEY THOMAS
|
N/A
|
|
+50K
|
$2.03
|
+$101.50K
|
|
SEC
|
BEHRS MELISSA KELLY
|
SVP Strategic Portfolio Mgmt
|
|
-25K
|
$4.28
|
-$108.12K
|
|
SEC
|
Bloom Olivia Kyusuk
|
VP, Chief Acctg Officer
|
|
-7K
|
$4.28
|
-$29.95K
|
|
SEC
|
EARP DAVID
|
Chief Legal Counsel
|
|
-25K
|
$4.28
|
-$108.12K
|
|
SEC
|
GREENWOOD DAVID
|
President, Interim CEO, CFO
|
|
-34K
|
$4.28
|
-$145.54K
|
|
SEC
|
Kelsey Stephen Michael
|
EVP, R&D Head, CMO
|
|
-4.9K
|
$4.28
|
-$20.79K
|
|
SEC
|
LEBKOWSKI JANE
|
SVP, Chief Scientific Officer
|
|
-25K
|
$4.28
|
-$108.12K
|
|
SEC
|
Spink Katharine E.
|
SVP Alliance Mgmt & Operations
|
|
-23K
|
$4.28
|
-$96.69K
|
|
SEC
|
BEHRS MELISSA KELLY
|
SVP Strategic Portfolio Mgmt
|
|
-3K
|
$4.47
|
-$13.30K
|
|
SEC
|
Bloom Olivia Kyusuk
|
VP, Chief Acctg Officer
|
|
-1.2K
|
$4.47
|
-$5.36K
|
|
SEC
|
EARP DAVID
|
SVP Bus Dev, Chief Patnt Couns
|
|
-3K
|
$4.47
|
-$13.30K
|
|
SEC
|
GREENWOOD DAVID
|
President, Interim CEO, CFO
|
|
-4.5K
|
$4.47
|
-$19.95K
|
|
SEC
|
LEBKOWSKI JANE
|
SVP, Chief Scientific Officer
|
|
-3K
|
$4.47
|
-$13.30K
|
|
SEC
|
Spink Katharine E.
|
SVP Prgm Mgmt, Cell Therapies
|
|
-419
|
$4.47
|
-$1.87K
|
|
SEC
|
Kelsey Stephen Michael
|
EVP, CMO, Oncology
|
|
-14K
|
$4.83
|
-$68.41K
|
|
SEC
|
BEHRS MELISSA KELLY
|
SVP Oncology
|
|
-11K
|
$5.43
|
-$57.65K
|
|
SEC
|
EARP DAVID
|
SVP Bus Dev, Chief Patnt Couns
|
|
-11K
|
$5.43
|
-$57.65K
|
|
SEC
|
GREENWOOD DAVID
|
EVP and CFO
|
|
-15K
|
$5.43
|
-$80.07K
|
|
SEC
|
LEBKOWSKI JANE
|
SVP, CSO Regen Med
|
|
-11K
|
$5.43
|
-$57.65K
|
|
SEC
|
OKARMA THOMAS
|
President and CEO
|
|
-19K
|
$5.43
|
-$102.49K
|
|
SEC
|
Spink Katharine E.
|
VP Operations, Regen Med Progs
|
|
-8.2K
|
$5.43
|
-$44.45K
|
|
SEC
|
BEHRS MELISSA KELLY
|
SVP Oncology
|
|
-2.3K
|
$5.11
|
-$11.94K
|
|
SEC
|
EARP DAVID
|
SVP Bus Dev, Chief Patnt Couns
|
|
-2.3K
|
$5.11
|
-$11.94K
|
|
SEC
|
GREENWOOD DAVID
|
EVP and CFO
|
|
-3.5K
|
$5.11
|
-$17.90K
|
|
SEC
|
LEBKOWSKI JANE
|
SVP, CSO Regen Med
|
|
-2.3K
|
$5.11
|
-$11.94K
|
|
SEC
|
OKARMA THOMAS
|
President and CEO
|
|
-4.7K
|
$5.11
|
-$23.87K
|
|
SEC
|
Spink Katharine E.
|
VP Operations, Regen Med Progs
|
|
-385
|
$5.11
|
-$1.97K
|
|
SEC
|
Kelsey Stephen Michael
|
EVP, CMO, Oncology
|
|
-3.7K
|
$5.66
|
-$20.98K
|
|
SEC
|
BEHRS MELISSA KELLY
|
SVP Oncology
|
|
-2.3K
|
$6.35
|
-$14.46K
|
|
SEC
|
Benedetti Fabio M
|
SVP, Chief Med Off, Oncology
|
|
-2.3K
|
$6.35
|
-$14.46K
|
|
SEC
|
EARP DAVID
|
SVP Bus Dev, Chief Patnt Couns
|
|
-2.3K
|
$6.35
|
-$14.46K
|
|
SEC
|
GREENWOOD DAVID
|
EVP and CFO
|
|
-3.4K
|
$6.35
|
-$21.69K
|
|
SEC
|
HARLEY CALVIN
|
VP, CSO Telomerase Tech
|
|
-2.3K
|
$6.35
|
-$14.46K
|
|
SEC
|
LEBKOWSKI JANE
|
SVP, CSO Regen Med
|
|
-2.3K
|
$6.35
|
-$14.46K
|
|
SEC
|
OKARMA THOMAS
|
President and CEO
|
|
-5.8K
|
$6.35
|
-$37.01K
|
|
SEC
|
Spink Katharine E.
|
VP Operations, Regen Med Progs
|
|
-400
|
$6.35
|
-$2.54K
|
|
SEC
|
BEHRS MELISSA KELLY
|
SVP Oncology
|
|
-6.8K
|
$6.75
|
-$46.03K
|
|
SEC
|
EARP DAVID
|
SVP Bus Dev, Chief Patnt Couns
|
|
-15K
|
$6.75
|
-$104.33K
|
|
SEC
|
GREENWOOD DAVID
|
EVP and CFO
|
|
-19K
|
$6.75
|
-$130.41K
|
|
SEC
|
HARLEY CALVIN
|
VP, CSO Telomerase Tech
|
|
-10K
|
$6.75
|
-$67.51K
|
|
SEC
|
LEBKOWSKI JANE
|
SVP, CSO Regen Med
|
|
-14K
|
$6.75
|
-$95.12K
|
|
SEC
|
OKARMA THOMAS
|
President and CEO
|
|
-47K
|
$6.75
|
-$315.02K
|
|
SEC
|
Spink Katharine E.
|
VP Operations, Regen Med Progs
|
|
-2.9K
|
$6.75
|
-$19.33K
|
|
SEC
|
Benedetti Fabio M
|
SVP, Chief Med Off, Oncology
|
|
-5.2K
|
$4.44
|
-$23.07K
|
|
SEC
|
BEHRS MELISSA KELLY
|
SVP Oncology
|
|
-15K
|
$8.12
|
-$119.89K
|
|
SEC
|
WALKER JOHN PETER
|
N/A
|
|
-49K
|
$8.28
|
-$402.55K
|
|
SEC
|
HARLEY CALVIN
|
VP and CSO
|
|
-30K
|
$7.09
|
-$216.17K
|
|
SEC
|
BEHRS MELISSA KELLY
|
SVP Oncology
|
|
-8.9K
|
$4.90
|
-$43.42K
|
|
SEC
|
EARP DAVID
|
SVP Bus Dev, Chief Patnt Couns
|
|
-8.9K
|
$4.90
|
-$43.42K
|
|
SEC
|
GREENWOOD DAVID
|
EVP and CFO
|
|
-11K
|
$4.90
|
-$52.59K
|
|
SEC
|
HARLEY CALVIN
|
VP and CSO
|
|
-8.9K
|
$4.90
|
-$43.42K
|
|
SEC
|
LEBKOWSKI JANE
|
SVP Regen Medicine
|
|
-8.9K
|
$4.90
|
-$43.42K
|
|
SEC
|
OKARMA THOMAS
|
President and CEO
|
|
-13K
|
$4.90
|
-$61.31K
|
|
SEC
|
BEHRS MELISSA KELLY
|
SVP Oncology
|
|
-24K
|
$4.05
|
-$96.57K
|
|
SEC
|
BEHRS MELISSA KELLY
|
SVP Oncology
|
|
-8.9K
|
$5.34
|
-$47.58K
|
|
SEC
|
EARP DAVID
|
SVP Bus Dev, Chief Patnt Couns
|
|
-8.9K
|
$5.34
|
-$47.58K
|
|
SEC
|
GREENWOOD DAVID
|
EVP and CFO
|
|
-11K
|
$5.34
|
-$58.95K
|
|
SEC
|
HARLEY CALVIN
|
VP and CSO
|
|
-8.9K
|
$5.34
|
-$47.58K
|
|
SEC
|
LEBKOWSKI JANE
|
SVP Regen Medicine
|
|
-8.9K
|
$5.34
|
-$47.58K
|
|
SEC
|
OKARMA THOMAS
|
President and CEO
|
|
-13K
|
$5.34
|
-$70.31K
|
|
SEC
|
GREENWOOD DAVID
|
EVP and CFO
|
|
-4K
|
$7.20
|
-$28.80K
|
|
SEC
|
HARLEY CALVIN
|
VP and CSO
|
|
-30K
|
$9.19
|
-$275.70K
|
|
SEC
|
BEHRS MELISSA KELLY
|
VP, Oncology
|
|
-8.4K
|
$8.56
|
-$72.25K
|
|
SEC
|
EARP DAVID
|
SVP Bus Dev / Chf Patent Couns
|
|
-11K
|
$8.56
|
-$96.92K
|
|
SEC
|
GREENWOOD DAVID
|
Executive VP and CFO
|
|
-12K
|
$8.56
|
-$104.29K
|
|
SEC
|
HARLEY CALVIN
|
Chief Scientific Officer
|
|
-9.2K
|
$8.56
|
-$78.61K
|
|
SEC
|
LEBKOWSKI JANE
|
SVP, Regenerative Medicine
|
|
-11K
|
$8.56
|
-$91.39K
|
|
SEC
|
OKARMA THOMAS
|
President and CEO
|
|
-12K
|
$8.56
|
-$105.46K
|
|
SEC
|
KELLY MELISSA
|
VP, Oncology
|
|
-66K
|
$10.88
|
-$713.41K
|
|
SEC
|
GREENWOOD DAVID
|
Executive VP and CFO
|
|
-30K
|
$10.45
|
-$313.50K
|
|
SEC
|
HARLEY CALVIN
|
Chief Scientific Officer
|
|
-25K
|
$10.46
|
-$261.50K
|
|
SEC
|
EARP DAVID
|
SVP Bus Dev / Chf Patent Couns
|
|
-9.2K
|
$8.57
|
-$79.18K
|
|
SEC
|
GREENWOOD DAVID
|
Executive VP, CFO
|
|
-14K
|
$8.57
|
-$118.30K
|
|
SEC
|
HARLEY CALVIN
|
Chief Scientific Officer
|
|
-9.9K
|
$8.57
|
-$85.09K
|
|
SEC
|
KELLY MELISSA
|
VP, Oncology
|
|
-8.6K
|
$8.57
|
-$74.11K
|
|
SEC
|
LEBKOWSKI JANE
|
SVP, Regenerative Medicine
|
|
-6.2K
|
$8.57
|
-$52.74K
|
|
SEC
|
OKARMA THOMAS
|
President and CEO
|
|
-14K
|
$8.57
|
-$122.41K
|
|
SEC
|
MERIX BIOSCIENCE INC
|
N/A
|
|
-66K
|
$5.57
|
-$364.84K
|
|
SEC
|
MERIX BIOSCIENCE INC
|
N/A
|
|
-47K
|
$5.52
|
-$259.44K
|
|
SEC
|
MERIX BIOSCIENCE INC
|
N/A
|
|
-168K
|
$5.95
|
-$999.01K
|
|
SEC
|
MERIX BIOSCIENCE INC
|
N/A
|
|
-42K
|
$5.46
|
-$229.32K
|
|
SEC
|
MERIX BIOSCIENCE INC
|
N/A
|
|
-102K
|
$5.28
|
-$535.92K
|
|
SEC
|
MERIX BIOSCIENCE INC
|
N/A
|
|
-35K
|
$5.52
|
-$193.20K
|
|
SEC
|
GREENWOOD DAVID
|
Sr. VP, Corp Dev and CFO
|
|
-6K
|
$9.51
|
-$57.06K
|
|
SEC
|
KELLY MELISSA
|
VP, Oncology
|
|
-2K
|
$9.60
|
-$19.48K
|
|
SEC
|
HARLEY CALVIN
|
Chief Scientific Officer
|
|
-6.3K
|
$9.23
|
-$58.34K
|
|
SEC
|
STEIN ROBERT B
|
N/A
|
|
-21K
|
$12.42
|
-$256.16K
|
|
SEC
|
STEIN ROBERT B
|
N/A
|
|
-15K
|
$12.50
|
-$188.13K
|
|
SEC
|
STEIN ROBERT B
|
N/A
|
|
-23K
|
$8.78
|
-$205.45K
|
|
SEC
|
GREENWOOD DAVID
|
Sr. VP, Corp Dev and CFO
|
|
-16K
|
$8.24
|
-$131.93K
|
|